Abstract
was poorer in the RT group with prostate cancer vs the general prostate cancer population, RT patients receiving surgery had a disease specific survival similar to that of the general prostate cancer population regardless of whether surgery was carried out before RT (p1⁄40.221) or after RT (p1⁄40.924). A similar finding was present in patients who were treated with EBRT. CONCLUSIONS: Immunosuppressed RT patients have been treated with surgery and EBRT in equal fashion. Patients receiving no therapy was very low. Type of therapy had no impact on survival and was similar to that of the general prostate cancer population.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
